• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用潜在类别混合建模验证罕见病研究的在线方法。

Validating online approaches for rare disease research using latent class mixture modeling.

机构信息

Boston College Connell School of Nursing, Chestnut Hill, MA, USA.

Massachusetts General Hospital - Harvard Center for Reproductive Medicine, Boston, MA, USA.

出版信息

Orphanet J Rare Dis. 2021 May 10;16(1):209. doi: 10.1186/s13023-021-01827-z.

DOI:10.1186/s13023-021-01827-z
PMID:33971926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8108361/
Abstract

BACKGROUND

Rare disease patients are geographically dispersed, posing challenges to research. Some researchers have partnered with patient organizations and used web-based approaches to overcome geographic recruitment barriers. Critics of such methods claim that samples are homogenous and do not represent the broader patient population-as patients recruited from patient organizations are thought to have high levels of needs. We applied latent class mixture modeling (LCMM) to define patient clusters based on underlying characteristics. We used previously collected data from a cohort of patients with congenital hypogonadotropic hypogonadism who were recruited online in collaboration with a patient organization. Patient demographics, clinical information, Revised Illness Perception Questionnaire (IPQ-R) scores and Zung self-rating depression Scale (SDS) were used as variables for LCMM analysis. Specifically, we aimed to test the classic critique that patients recruited online in collaboration with a patient organization are a homogenous group with high needs. We hypothesized that distinct classes (clinical profiles) of patients could be identified-thereby demonstrating the validity of online recruitment and supporting transferability of findings.

RESULTS

In total, 154 patients with CHH were included. The LCMM analysis identified three distinct subgroups (Class I: n = 84 [54.5%], Class II: n = 41 [26.6%], Class III: n = 29 [18.8%]) that differed significantly in terms of age, education, disease consequences, emotional consequences, illness coherence and depression symptoms (all p < 0.001) as well as age at diagnosis (p = 0.045). Classes depict a continuum of psychosocial impact ranging from severe to relatively modest. Additional analyses revealed later diagnosis (Class I: 19.2 ± 6.7 years [95% CI 17.8-20.7]) is significantly associated with worse psychological adaptation and coping as assessed by disease consequences, emotional responses, making sense of one's illness and SDS depressive symptoms (all p < 0.001).

CONCLUSIONS

We identify three distinct classes of patients who were recruited online in collaboration with a patient organization. Findings refute prior critiques of patient partnership and web-based recruitment for rare disease research. This is the first empirical data suggesting negative psychosocial sequelae of later diagnosis ("diagnostic odyssey") often observed in CHH.

摘要

背景

罕见病患者分布在不同的地区,这给研究带来了挑战。一些研究人员与患者组织合作,并采用基于网络的方法来克服地理招募障碍。此类方法的批评者认为,样本具有同质性,不能代表更广泛的患者群体,因为从患者组织招募的患者被认为有较高的需求。我们应用潜在类别混合模型(LCMM)来根据潜在特征定义患者群。我们使用先前从一个与患者组织合作招募的先天性低促性腺激素性性腺功能减退症患者队列中收集的数据。患者人口统计学、临床信息、修订后的疾病感知问卷(IPQ-R)评分和 Zung 自评抑郁量表(SDS)被用作 LCMM 分析的变量。具体来说,我们旨在检验在线与患者组织合作招募的患者是一个具有高度需求的同质群体的这一经典批评。我们假设可以识别出不同的患者群体(临床特征),从而证明在线招募的有效性,并支持研究结果的可转移性。

结果

共纳入 154 例 CHH 患者。LCMM 分析确定了三个不同的亚组(I 类:n=84[54.5%],II 类:n=41[26.6%],III 类:n=29[18.8%]),这些亚组在年龄、教育程度、疾病后果、情绪后果、疾病连贯性和抑郁症状(均 P<0.001)以及诊断年龄(P=0.045)方面存在显著差异。这些类别描绘了从严重到相对较轻的心理社会影响连续体。进一步的分析表明,较晚的诊断(I 类:19.2±6.7 岁[95%CI 17.8-20.7])与疾病后果、情绪反应、对疾病的理解和 SDS 抑郁症状评估的较差的心理适应和应对能力显著相关(均 P<0.001)。

结论

我们确定了三个不同的患者亚组,他们是通过与患者组织合作在线招募的。研究结果驳斥了先前对患者合作和基于网络的罕见病研究招募的批评。这是首次有实证数据表明,在 CHH 中经常观察到的较晚诊断(“诊断之旅”)会带来负面的心理社会后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569d/8108361/5147282dbebd/13023_2021_1827_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569d/8108361/b3f9d63dbf9e/13023_2021_1827_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569d/8108361/5147282dbebd/13023_2021_1827_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569d/8108361/b3f9d63dbf9e/13023_2021_1827_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569d/8108361/5147282dbebd/13023_2021_1827_Fig2_HTML.jpg

相似文献

1
Validating online approaches for rare disease research using latent class mixture modeling.使用潜在类别混合建模验证罕见病研究的在线方法。
Orphanet J Rare Dis. 2021 May 10;16(1):209. doi: 10.1186/s13023-021-01827-z.
2
Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres.男性先天性低促性腺激素性性腺功能减退症患者逆转的分类和预测因素:六个国际转诊中心的横断面研究。
Lancet Diabetes Endocrinol. 2024 Apr;12(4):257-266. doi: 10.1016/S2213-8587(24)00028-7. Epub 2024 Mar 1.
3
Developing and evaluating rare disease educational materials co-created by expert clinicians and patients: the paradigm of congenital hypogonadotropic hypogonadism.开发和评估由临床专家和患者共同创作的罕见病教育材料:先天性低促性腺激素性性腺功能减退症的范例
Orphanet J Rare Dis. 2017 Mar 20;12(1):57. doi: 10.1186/s13023-017-0608-2.
4
Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support.使用基于网络的需求评估来识别先天性低促性腺激素性性腺功能减退患者未满足的健康需求:对在线干预和同伴支持的启示
Orphanet J Rare Dis. 2014 Jun 11;9:83. doi: 10.1186/1750-1172-9-83.
5
Adherence to treatment in men with hypogonadotrophic hypogonadism.性腺功能减退性性腺功能减退男性对治疗的依从性。
Clin Endocrinol (Oxf). 2017 Mar;86(3):377-383. doi: 10.1111/cen.13236. Epub 2017 Jan 11.
6
Beyond hormone replacement: quality of life in women with congenital hypogonadotropic hypogonadism.超越激素替代疗法:先天性低促性腺激素性性腺功能减退女性的生活质量
Endocr Connect. 2017 Aug;6(6):404-412. doi: 10.1530/EC-17-0095. Epub 2017 Jul 11.
7
Psychosexual development in men with congenital hypogonadotropic hypogonadism on long-term treatment: a mixed methods study.男性先天性低促性腺激素性性腺功能减退症患者长期治疗后的性心理发展:一项混合方法研究。
Sex Med. 2015 Mar;3(1):32-41. doi: 10.1002/sm2.50.
8
Psychological Aspects of Congenital Hypogonadotropic Hypogonadism.先天性低促性腺激素性性腺功能减退的心理方面
Front Endocrinol (Lausanne). 2019 Jul 5;10:353. doi: 10.3389/fendo.2019.00353. eCollection 2019.
9
Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.先天性低促性腺激素性性腺功能减退伴嗅觉缺失和 Gorlin 特征,由 PTCH1 突变引起,揭示了 Kallmann 综合征的一个新候选基因。
Neuroendocrinology. 2021;111(1-2):99-114. doi: 10.1159/000506640. Epub 2020 Feb 20.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Effect of pubertal induction with combined gonadotropin therapy on testes development and spermatogenesis in males with gonadotropin deficiency: a cohort study.联合促性腺激素疗法诱导青春期对促性腺激素缺乏男性睾丸发育和精子发生的影响:一项队列研究
Hum Reprod Open. 2025 May 13;2025(2):hoaf026. doi: 10.1093/hropen/hoaf026. eCollection 2025.
2
Nursing's Role in Advancing Care for Rare Genetic Diseases.护理在推进罕见遗传病护理中的作用。
Nurs Clin North Am. 2025 Jun;60(2):349-368. doi: 10.1016/j.cnur.2024.12.005. Epub 2025 Mar 3.
3
Outcomes and experiences of adults with congenital hypogonadism can inform improvements in the management of delayed puberty.

本文引用的文献

1
Facebook Support Groups for Rare Pediatric Diseases: Quantitative Analysis.罕见儿科疾病的脸书支持小组:定量分析
JMIR Pediatr Parent. 2020 Nov 19;3(2):e21694. doi: 10.2196/21694.
2
Evaluating co-created patient-facing materials to increase understanding of genetic test results.评估共同创作的面向患者的材料,以提高对基因检测结果的理解。
J Genet Couns. 2021 Apr;30(2):598-605. doi: 10.1002/jgc4.1348. Epub 2020 Oct 24.
3
Psychosexual effects resulting from delayed, incomplete, or absent puberty.青春期延迟、不完全或缺失所导致的性心理影响。
先天性性腺功能减退症成年患者的结局和体验可为改善青春期延迟的管理提供信息。
J Pediatr Endocrinol Metab. 2023 Nov 24;37(1):1-7. doi: 10.1515/jpem-2023-0407. Print 2024 Jan 29.
4
Advancing qualitative rare disease research methodology: a comparison of virtual and in-person focus group formats.推进定性罕见病研究方法学:虚拟与面对面焦点小组形式的比较。
Orphanet J Rare Dis. 2022 Sep 11;17(1):354. doi: 10.1186/s13023-022-02522-3.
5
Exploring Rare Disease Patient Attitudes and Beliefs regarding Genetic Testing: Implications for Person-Centered Care.探索罕见病患者对基因检测的态度和信念:对以患者为中心的护理的启示。
J Pers Med. 2022 Mar 16;12(3):477. doi: 10.3390/jpm12030477.
6
Evidence that perinatal ovarian hormones promote women's sexual attraction to men.围产期卵巢激素促使女性对男性产生性吸引力的证据。
Psychoneuroendocrinology. 2021 Sep 27;134:105431. doi: 10.1016/j.psyneuen.2021.105431.
Curr Opin Endocr Metab Res. 2020 Oct;14:15-21. doi: 10.1016/j.coemr.2020.04.003. Epub 2020 Apr 24.
4
A review of reviews on principles, strategies, outcomes and impacts of research partnerships approaches: a first step in synthesising the research partnership literature.对研究伙伴关系方法的原则、策略、结果和影响的综述:综合研究伙伴关系文献的第一步。
Health Res Policy Syst. 2020 May 25;18(1):51. doi: 10.1186/s12961-020-0544-9.
5
A novel approach to conducting clinical trials in the community setting: utilizing patient-driven platforms and social media to drive web-based patient recruitment.一种在社区环境中开展临床试验的新方法:利用患者驱动的平台和社交媒体来推动基于网络的患者招募。
BMC Med Res Methodol. 2020 Mar 13;20(1):58. doi: 10.1186/s12874-020-00926-y.
6
Identifying subgroups: Part 2: Trajectories of change over time.识别亚组:第 2 部分:随时间变化的轨迹。
Eur J Cardiovasc Nurs. 2020 Jun;19(5):444-450. doi: 10.1177/1474515120911330. Epub 2020 Mar 4.
7
Identifying subgroups: Part 1: Patterns among cross-sectional data.识别亚组:第 1 部分:横断面数据中的模式。
Eur J Cardiovasc Nurs. 2020 Apr;19(4):359-365. doi: 10.1177/1474515120911323. Epub 2020 Mar 3.
8
Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.罕见病研究试验的完成和发表情况:一项横断面分析。
PLoS Med. 2019 Nov 21;16(11):e1002966. doi: 10.1371/journal.pmed.1002966. eCollection 2019 Nov.
9
Recruitment via social media: advantages and potential biases.通过社交媒体进行招募:优势与潜在偏差。
Digit Health. 2019 Aug 6;5:2055207619867223. doi: 10.1177/2055207619867223. eCollection 2019 Jan-Dec.
10
A Critical Discussion of Patient Engagement in Research.关于患者参与研究的批判性讨论
J Patient Cent Res Rev. 2017 Jan 31;4(1):39-41. doi: 10.17294/2330-0698.1273. eCollection 2017 Winter.